Intrinsic Value of S&P & Nasdaq Contact Us

Adicet Bio, Inc. ACET NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+157.1%

Adicet Bio, Inc. (ACET) has 20 known insider and institutional holders on record. The largest holder is ORBIMED ADVISORS LLC with 4,490,254 shares. Other notable holders include PureTech Health LLC and Schindel Yair Chaim.

Over the last 12 months, insiders have made 17 transactions in ACET stock — 12 buys (valued at $8.33M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

ACET Insider Ownership

Top Holder
ORBIMED ADVISORS LLC
4,490,254 shares
Buys (12 mo)
12
$8.33M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 71%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Orbimed Advisors Llc 10 Percent Owner 4,490,254 2025-10-10
100%
2 Puretech Health Llc 10 Percent Owner 2,119,696 2019-12-19
47%
3 Schindel Yair Chaim Director 1,104,460 2020-09-17
25%
4 Schor Chen President & CEO 468,555 2026-03-27
10%
5 Chimovits Erez 10 Percent Owner 396,657 2021-02-18
9%
6 Galimi Francesco SVP & Chief Medical Officer 375,077 2024-06-07
8%
7 Mannick Joan Chief Medical Officer 88,667 2019-12-06
2%
8 Aftab Blake Chief Scientific Officer 72,555 2026-03-27
2%
9 Maltzman Julia D. Chief Medical Officer 72,555 2026-03-27
2%
10 Grissinger Michael Director 70,200 2025-04-21
2%
11 Borkowski Edward Chief Financial Officer 60,000 2018-02-22
1%
12 Healey Don Chief Technology Officer 43,361 2026-03-27
1%
13 Harvey Brian Nicholas Chief Financial Officer 43,361 2026-03-27
1%
14 Randall Richard P Director 31,090 2013-12-06
1%
15 Klickstein Lloyd Director 26,400 2025-06-13
1%
16 Manning Meredith Chief Commercial Officer 26,000 2019-02-28
1%
17 Dubin Steve Director 22,700 2025-06-13
1%
18 Giordano Natasha Director 20,972 2017-12-11
0%
19 Chodakewitz Jeffrey Director 17,700 2025-06-13
0%
20 Sinclair Andrew Director 17,700 2025-06-13
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-25 Maltzman Julia D. Chief Medical Officer RSU Award 72,555 $6.81 $494.1K
2026-03-25 Aftab Blake Chief Scientific Officer RSU Award 72,555 $6.81 $494.1K
2026-03-25 Healey Don Chief Technology Officer RSU Award 43,361 $6.81 $295.29K
2026-03-25 Harvey Brian Nicholas Chief Financial Officer RSU Award 43,361 $6.81 $295.29K
2026-03-25 Schor Chen President & CEO RSU Award 468,555 $6.81 $3.19M
2026-01-24 Aftab Blake Chief Scientific Officer Tax Withholding of RSU 535 $8.44 $4.52K
2026-01-24 Healey Don Chief Technology Officer Tax Withholding of RSU 535 $8.44 $4.52K
2026-01-24 Harvey Brian Nicholas Chief Financial Officer Tax Withholding of RSU 546 $8.44 $4.61K
2026-01-24 Schor Chen President & CEO Tax Withholding of RSU 1,755 $8.44 $14.81K
2025-10-08 Orbimed Advisors Llc 10 Percent Owner Informative Buy 3,500,000 $1.00 $3.5M
2025-06-11 Peng Katie Director RSU Award 5,900 - -
2025-06-11 Klickstein Lloyd Director RSU Award 26,400 $0.78 $20.59K
2025-06-11 Sinclair Andrew Director RSU Award 5,900 - -
2025-06-11 Chodakewitz Jeffrey Director RSU Award 5,900 - -
2025-06-11 Dubin Steve Director RSU Award 5,900 - -
2025-04-17 Grissinger Michael Director RSU Award 70,200 $0.53 $36.91K
2025-04-17 Grissinger Michael Officer Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message